Article Type
Original Research
Published
This study aimed to evaluate the effectiveness of tildrakizumab in treating moderate-to-severe psoriasis within a real-world setting over a 52-week period in Portugal.
Tag: tildrakizumab
Article Type
Erratum
Published
The authors wish to make the following corrections to their article: Burlando M, Castelli R, Cozzani E, Parodi A. Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting. Drugs in Context 2021; 10: 2021-2-6. DOI: 10.7573/dic.2021-2-6
Article Type
Original Research
Published
This article reports experiences with tildrakizumab as they may be helpful to dermatologists to maximize the
efficiency of this therapy.
